PMS39 COST-UTILITY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INSUFFICIENT RESPONSE OR INTOLERANCE TO ANTI-TNF THERAPY IN ITALY- A PROBABILISTIC SENSITIVITY ANALYSIS

Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66808-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)66808-8/fulltext
Title : PMS39 COST-UTILITY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INSUFFICIENT RESPONSE OR INTOLERANCE TO ANTI-TNF THERAPY IN ITALY- A PROBABILISTIC SENSITIVITY ANALYSIS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66808-8&doi=10.1016/S1098-3015(10)66808-8
First page :
Section Title :
Open access? : No
Section Order : 641
Categories :
Tags :
Regions :
ViH Article Tags :